Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Annukka Paju & Ulf-Håkan Stenman. (2006) Biochemistry and Clinical Role of Trypsinogens and Pancreatic Secretory Trypsin Inhibitor. Critical Reviews in Clinical Laboratory Sciences 43:2, pages 103-142.
Read now
Read now
Professor Gianfranco Tramonti, Marco Ferdeghini, Carlo Donadio, Carmela Annichiarico, Maria Norpoth, Romano Bianchi & Claudio Bianchi. (1998) Serum Levels of Tumor Associated Trypsin Inhibitor (TATT) and Glomerular Filtration Rate. Renal Failure 20:2, pages 295-302.
Read now
Read now
G. Tramonti, C. Donadio, M. Ferdeghini, C. Annichiarico, M. Norpoth, R. Bianchi & C. Bianchi. (1996) Serum tumour-associated trypsin inhibitor (TATI) and renal function. Scandinavian Journal of Clinical and Laboratory Investigation 56:7, pages 653-656.
Read now
Read now
Ulf-Håkan Stenman, Henrik Alfthan, Juhani Vartiainen & Pentti Lehtovirta. (1995) Markers Supplementing CA 125 in Ovarian Cancer. Annals of Medicine 27:1, pages 115-120.
Read now
Read now
J. E. Reseland, H. Holm, T. Jenssen, M. B. Jacobsen & L. E. Hanssen. (1995) Inhibitor-Stimulated Non-Parallel Pancreatic Secretion in Man: Hormonal and Neural Regulation?. Scandinavian Journal of Gastroenterology 30:1, pages 72-80.
Read now
Read now
L. Halme, K. Von Smitten, S. Stenman, U. Turpeinen & U.-H. Stenman. (1993) Concentrations of pancreatic secretory trypsin inhibitor (PSTI), acute phase proteins, and neopterin in Crohn's disease. Comparison with clinical disease activity and endoscopical findings. Scandinavian Journal of Clinical and Laboratory Investigation 53:4, pages 359-366.
Read now
Read now
Articles from other publishers (34)
GhadaM Habib, Ahmed Ramadan, Mervat El-Ansary, Zeinab Abdellatif, Magdy El-Serafy & Hussein Okasha. (2022) Value of pancreatic cyst fluid SPINK1 and glucose in differentiating potentially malignant cysts from those of benign nature: A prospective cohort study. Saudi Journal of Gastroenterology 28:5, pages 348.
Crossref
Crossref
Milena Matuszczak & Maciej Salagierski. (2020) Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers. International Journal of Molecular Sciences 21:9, pages 3360.
Crossref
Crossref
Chengliang Zhu, Huan Han, Jie Li, Limin Xu, Fang Liu, Kailang Wu & Xinghui Liu. (2019) Hepatitis B Virus X Protein-Induced Serine Protease Inhibitor Kazal Type 1 Is Associated with the Progression of HBV-Related Diseases. BioMed Research International 2019, pages 1-7.
Crossref
Crossref
Barbara Kozakiewicz, Małgorzata Chądzyńska, Ewa Dmoch-Gajzlerska & Małgorzata Stefaniak. (2015) Tumor-Associated Trypsin Inhibitor in Patients with Endometrial Cancer. Tumori Journal 102:5, pages 527-532.
Crossref
Crossref
Jaime H. NoguezCorinne R. Fantz. (2014) Pathology Consultation on Prostate-Specific Antigen Testing. American Journal of Clinical Pathology 142:1, pages 7-15.
Crossref
Crossref
Yu Man Ching Kelvin, Jin-Seok Park & Dong-Wan Seo. (2014) Role of endosonography in the management of incidental pancreatic cystic lesions. Gastrointestinal Intervention 3:1, pages 40-45.
Crossref
Crossref
Hatem A. El-mezayen, Fatheya M. Metwally & Hossam Darwish. (2013) A novel discriminant score based on tumor-associated trypsin inhibitor for accurate diagnosis of metastasis in patients with breast cancer. Tumor Biology 35:3, pages 2759-2767.
Crossref
Crossref
Sari Räty, Juhani Sand, Johanna Laukkarinen, Kaija Vasama, Claudio Bassi, Roberto Salvia & Isto Nordback. (2013) Cyst fluid SPINK1 may help to differentiate benign and potentially malignant cystic pancreatic lesions. Pancreatology 13:5, pages 530-533.
Crossref
Crossref
Nobuyuki Ozaki, Masaki Ohmuraya, Satoshi Ida, Daisuke Hashimoto, Yoshiaki Ikuta, Akira Chikamoto, Masahiko Hirota & Hideo Baba. (2013) Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia. Journal of Hepato-Biliary-Pancreatic Sciences 20:6, pages 620-627.
Crossref
Crossref
Selja Koskensalo, Jaana Hagström, Johanna Louhimo, Ulf-Håkan Stenman & Caj Haglund. (2012) Tumour-Associated Trypsin Inhibitor TATI Is a Prognostic Marker in Colorectal Cancer. Oncology 82:4, pages 234-241.
Crossref
Crossref
Masaki OHMURAYA & Ken-ichi YAMAMURA. (2011) The Roles of Serine Protease Inhibitor Kazal Type 1 (SPINK1) in Pancreatic Diseases. Experimental Animals 60:5, pages 433-444.
Crossref
Crossref
Alexander Gaber, Björn Nodin, Kristina Hotakainen, Elise Nilsson, Ulf-Håkan Stenman, Anders Bjartell, Helgi Birgisson & Karin Jirström. (2010) Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients. BMC Cancer 10:1.
Crossref
Crossref
Dorthe Johansen, Jonas Manjer, Sara Regner & Björn Lindkvist. (2010) Pre-Diagnostic Levels of AnionicTrypsinogen, Cationic Trypsinogen, and Pancreatic Secretory Trypsin Inhibitor in Relation to Pancreatic Cancer Risk. Pancreatology 10:2-3, pages 229-237.
Crossref
Crossref
Nobuyuki Ozaki, Masaki Ohmuraya, Masahiko Hirota, Satoshi Ida, Jun Wang, Hiroshi Takamori, Shigeki Higashiyama, Hideo Baba & Ken-ichi Yamamura. (2009) Serine Protease Inhibitor Kazal Type 1 Promotes Proliferation of Pancreatic Cancer Cells through the Epidermal Growth Factor Receptor. Molecular Cancer Research 7:9, pages 1572-1581.
Crossref
Crossref
K Soreide, EA Janssen, H Körner & JPA Baak. (2006) Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion, and metastasis. The Journal of Pathology 209:2, pages 147-156.
Crossref
Crossref
W G Jiang, M C A Puntis & M B Hallett. (1994) Molecular and cellular basis of cancer invasion and metastasis: Implications for treatment. British Journal of Surgery 81:11, pages 1576-1590.
Crossref
Crossref
Shahrokh F. Shariat, Michael P. Herman, Roberto Casella, Yair Lotan, Jose A. Karam & Ulf-Håkan Stenman. (2005) Urinary Levels of Tumor-Associated Trypsin Inhibitor (TATI) in the Detection of Transitional Cell Carcinoma of the Urinary Bladder. European Urology 48:3, pages 424-431.
Crossref
Crossref
Susanna Lintula, Jakob Stenman, Anders Bjartell, Stig Nordling & Ulf-H�kan Stenman. (2005) Relative concentrations of hK2/PSA mRNA in benign and malignant prostatic tissue. The Prostate 63:4, pages 324-329.
Crossref
Crossref
J-P Wiksten, J Lundin, S Nordling, A Kokkola, U-H Stenman & C Haglund. (2005) High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer. Histopathology 46:4, pages 380-388.
Crossref
Crossref
Annukka Paju, Juhani Vartiainen, Caj Haglund, Outi Itkonen, Kristina von Boguslawski, Arto Leminen, Torsten Wahlström & Ulf-Håkan Stenman. (2004) Expression of Trypsinogen-1, Trypsinogen-2, and Tumor-Associated Trypsin Inhibitor in Ovarian Cancer. Clinical Cancer Research 10:14, pages 4761-4768.
Crossref
Crossref
Sylvia Solakidi, Athanassios Dessypris, George P Stathopoulos, George Androulakis & Constantine E Sekeris. (2004) Tumour-associated trypsin inhibitor, carcinoembryonic antigen and acute-phase reactant proteins CRP and α1-antitrypsin in patients with gastrointestinal malignancies. Clinical Biochemistry 37:1, pages 56-60.
Crossref
Crossref
Katariina Cederqvist, Caj Haglund, Päivi Heikkilä, Timo Sorsa, Taina Tervahartiala, Ulf-Håkan Stenman & Sture Andersson. (2003) Pulmonary Trypsin-2 in the Development of Bronchopulmonary Dysplasia in Preterm Infants. Pediatrics 112:3, pages 570-577.
Crossref
Crossref
Darci Tackels-Horne, M. David Goodman, Amanda J. Williams, Daniel J. Wilson, Tara Eskandari, Lisa M. Vogt, Joseph F. Boland, Uwe Scherf & Joseph G. Vockley. (2001) Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling. Cancer 92:2, pages 395-405.
Crossref
Crossref
ANNUKKA PAJU, JAN JACOBSEN, TORGNY RASMUSON, ULF-H??KAN STENMAN & B??RJE LJUNGBERG. (2001) TUMOR ASSOCIATED TRYPSIN INHIBITOR AS A PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA. The Journal of Urology, pages 959-962.
Crossref
Crossref
ANNUKKA PAJU, JAN JACOBSEN, TORGNY RASMUSON, ULF-HÅKAN STENMAN & BÖRJE LJUNGBERG. (2001) TUMOR ASSOCIATED TRYPSIN INHIBITOR AS A PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA. Journal of Urology 165:3, pages 959-962.
Crossref
Crossref
Leila Unkila-Kallio, Aila Tiitinen, Henrik Alfthan, Piia Vuorela, Ulf-Håkan Stenman & Olavi Ylikorkala. (2000) Effect of an in vitro fertilization program on serum CA 125, tumor-associated trypsin inhibitor, free β-subunit of human chorionic gonadotropin, and common α-subunit of glycoprotein hormones. Fertility and Sterility 74:6, pages 1125-1132.
Crossref
Crossref
Annukka Lukkonen, Susanna Lintula, Kristina von Boguslawski, Olli Carp�n, B�rje Ljungberg, G�ran Landberg & Ulf-H�kan Stenman. (1999) Tumor-associated trypsin inhibitor in normal and malignant renal tissue and in serum of renal-cell carcinoma patients. International Journal of Cancer 83:4, pages 486-490.
Crossref
Crossref
M. Wald, T. Olejár, P. Poučková & M. Zadinová. (1998) Proteinases reduce metastatic dissemination and increase survival time in C57Bl6 mice with the Lewis lung carcinoma. Life Sciences 63:17, pages PL237-PL243.
Crossref
Crossref
Pekka Venesmaa, Ulf‐Håkan Stenman, Matti Forss, Arto Leminen, Pentti Lehtovirta, Juhani Vartiainen & Jorma Paavonen. (2005) Pre‐operative serum level of tumour‐associated trypsin inhibitor and residual turnour size as prognostic indicators in Stage III epithelial ovarian cancer. BJOG: An International Journal of Obstetrics & Gynaecology 105:5, pages 508-511.
Crossref
Crossref
Outi Itkonen, Ulf-Håkan Stenman, Sirpa Osman, Erkki Koivunen, Hannu Halila & Tom Schröder. (1996) Serum samples from pancreatectomized patients contain trypsinogen immunoreactivity. Journal of Laboratory and Clinical Medicine 128:1, pages 98-102.
Crossref
Crossref
Janne E. Reseland, Halvor Holm, Morten B. Jacobsen, Trond G. Jenssen & Lars E. Hanssen. (1996) Proteinase Inhibitors Induce Selective Stimulation of Human Trypsin and Chymotrypsin Secretion. The Journal of Nutrition 126:3, pages 634-642.
Crossref
Crossref
Taro Hayakawa, Kyoko Yamashita, Eiko Ohuchi & Akira Shinagawa. (1994) Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). Journal of Cell Science 107:9, pages 2373-2379.
Crossref
Crossref
Yoshitaka Ohmachi, Atsuo Murata, Nariaki Matsuura, Tadashi Yasuda, Ken-ichi Uda & Takesada Mori. (1994) Overexpression of pancreatic secretory trypsin inhibitor in pancreatic cancer. International journal of pancreatology 15:1.
Crossref
Crossref
Wen-Tien Chen. (1992) Membrane proteases: roles in tissue remodeling and tumour invasion. Current Opinion in Cell Biology 4:5, pages 802-809.
Crossref
Crossref